Leap Therapeutics

$Leap Therapeutics(LPTX)$ 8-K Current report, items 5.02, 5.03, 5.07, 8.01, and 9.01 Accession Number: 0001104659-25-121566  Act: 34  Size: 418 KB 网页链接

$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-111432  Size: 10 KB 网页链接

$Leap Therapeutics(LPTX)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-25-110341  Act: 34  Size: 696 KB 网页链接

$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-114094  Size: 10 KB 网页链接

$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-114093  Size: 6 KB 网页链接

$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-111446  Size: 6 KB 网页链接

$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-111449  Size: 6 KB 网页链接

$Leap Therapeutics(LPTX)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-25-114435  Act: 34  Size: 228 KB 网页链接

$Leap Therapeutics(LPTX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001231919-25-000541  Size: 15 KB 网页链接

$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-114084  Size: 10 KB 网页链接

$Leap Therapeutics(LPTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001104659-25-109827  Act: 34  Size: 6 MB 网页链接

$Leap Therapeutics(LPTX)$ 塞弗恩斯·肖恩·迈克尔已向美国证券交易委员会（SEC）提交了13G表格，披露其持有Cypherpunk Technologies Inc. 6,000,000股普通股的实益所有权，占该公司已发行股份的10.59%。该文件表明塞弗恩斯对这些股份拥有独立投票权和处置权。此次申报根据Rule 13d-1(c)条款进行...

$Leap Therapeutics(LPTX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-25-111427  Size: 12 KB 网页链接

$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-111452  Size: 6 KB 网页链接

$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-111434  Size: 6 KB 网页链接

$Leap Therapeutics(LPTX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-25-114086  Act: 34  Size: 340 KB 网页链接

$Leap Therapeutics(LPTX)$ 8-K Current report, items 1.01, 2.02, 5.02, 5.03, 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-109820  Act: 34  Size: 1 MB 网页链接

$Leap Therapeutics(LPTX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-25-109899  Act: 33  Size: 467 KB 网页链接

$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001231919-25-000542  Size: 13 KB 网页链接

$Leap Therapeutics(LPTX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-25-114713  Size: 21 KB 网页链接